<p>Serious adverse events (SAE) reported for the period 1–5 months after the 2009 AS03-adjuvanted monovalent pandemic vaccine.</p
Abstract: Aim: This is the first annual report for NSW of adverse events following immunisation. It ...
<p>A full listing of SAEs is provided in <a href="http://www.plosmedicine.org/article/info:doi/10.13...
In preparation for pandemic vaccine safety monitoring, we assessed adverse events reported to the Va...
This study assessed the short and the long term safety of the 2009 AS03 adjuvanted monovalent pandem...
This study assessed the short and the long term safety of the 2009 AS03 adjuvanted monovalent pandem...
Background: This study assessed the short and the long term safety of the 2009 AS03 adjuvanted monov...
<p>Abbreviation: CNS, central nervous system; IRR, incidence rate ratio; CI, confidence interval.</p...
<p>*reported as possibly related.</p><p>Adverse events (AEs) during trial period (day 0–182) by vacc...
<p>Abbreviation: CNS, central nervous system; IRR, incidence rate ratio; CI, confidence interval.</p...
<p>LAIV = live attenuated influenza vaccine; IIV = inactivated influenza vaccination; AE = adverse e...
The influenza A (H1N1) virus emerged in the United States in the spring of 2009, initiating a progra...
The influenza A (H1N1) virus emerged in the United States in the spring of 2009, initiating a progra...
The influenza A (H1N1) virus emerged in the United States in the spring of 2009, initiating a progra...
The influenza A (H1N1) virus emerged in the United States in the spring of 2009, initiating a progra...
Adverse events following first and second immunization of COVID-19 among the participants.</p
Abstract: Aim: This is the first annual report for NSW of adverse events following immunisation. It ...
<p>A full listing of SAEs is provided in <a href="http://www.plosmedicine.org/article/info:doi/10.13...
In preparation for pandemic vaccine safety monitoring, we assessed adverse events reported to the Va...
This study assessed the short and the long term safety of the 2009 AS03 adjuvanted monovalent pandem...
This study assessed the short and the long term safety of the 2009 AS03 adjuvanted monovalent pandem...
Background: This study assessed the short and the long term safety of the 2009 AS03 adjuvanted monov...
<p>Abbreviation: CNS, central nervous system; IRR, incidence rate ratio; CI, confidence interval.</p...
<p>*reported as possibly related.</p><p>Adverse events (AEs) during trial period (day 0–182) by vacc...
<p>Abbreviation: CNS, central nervous system; IRR, incidence rate ratio; CI, confidence interval.</p...
<p>LAIV = live attenuated influenza vaccine; IIV = inactivated influenza vaccination; AE = adverse e...
The influenza A (H1N1) virus emerged in the United States in the spring of 2009, initiating a progra...
The influenza A (H1N1) virus emerged in the United States in the spring of 2009, initiating a progra...
The influenza A (H1N1) virus emerged in the United States in the spring of 2009, initiating a progra...
The influenza A (H1N1) virus emerged in the United States in the spring of 2009, initiating a progra...
Adverse events following first and second immunization of COVID-19 among the participants.</p
Abstract: Aim: This is the first annual report for NSW of adverse events following immunisation. It ...
<p>A full listing of SAEs is provided in <a href="http://www.plosmedicine.org/article/info:doi/10.13...
In preparation for pandemic vaccine safety monitoring, we assessed adverse events reported to the Va...